← Back to Search

Laparoscopic Assisted Partial Nephrectomy for Renal Masses (RALPLPNNX Trial)

Phase 3
Waitlist Available
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

RALPLPNNX Trial Summary

This trial looks at whether RALPN or LPN is better for patients with a small renal mass.

RALPLPNNX Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Warm ischemia time
Secondary outcome measures
Complication rates as per Clavien-Dindo classification
Conversion rate to radical nephrectomy or OPN due to technical difficulty.
Therapeutic procedure
+5 more

RALPLPNNX Trial Design

2Treatment groups
Active Control
Group I: Laparoscopic Assisted Partial NephrectomyActive Control1 Intervention
Current standard for partial nephrectomies.
Group II: Robotic Assisted Partial NephrectomyActive Control1 Intervention
Possible new standard for partial nephrectomies.

Find a Location

Who is running the clinical trial?

St. Joseph's Healthcare HamiltonLead Sponsor
196 Previous Clinical Trials
25,440 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in this clinical trial for new participants?

"According to the latest information on clinicaltrials.gov, this study is no longer recruiting patients for participation. The trial was originally posted on December 1st 2021 but has not been updated since March 17th 2021. There are, however, 3 other similar trials that are still looking for participants."

Answered by AI

Are there any dangers associated with Robotic Assisted Partial Nephrectomy?

"Robotic Assisted Partial Nephrectomy, which is a phase 3 trial, has some efficacy data supporting it and multiple rounds of safety data, so our team rates its safety at a 3."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Trial Comparing - Robotic Assisted Versus Laparoscopic Partial Nephrectomy For Small Renal Masses
Anil Kapoor 2021. "A Trial Comparing - Robotic Assisted Versus Laparoscopic Partial Nephrectomy For Small Renal Masses". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02933398.
~31 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top